2008-10-31 Avid's phase III trials

張貼者:2008年10月30日 下午4:08林昆儒   [ 已更新 2008年10月30日 下午4:20 ]

26 Oct 2008 - 0:00 PDT | by Medical news today |

Avid's imaging compound to benefit from FDA support of agents

美國FDA建議 amyloid imaging agents 可以協助Alzheimer's disease的診斷。而 Avid Radiopharmaceuticals 將進一步把該藥廠的新造影藥物AV-45推向第三期人體試驗 。
 

Avid intends to work closely with the agency in its Phase III clinical program for the imaging agent.

Daniel Skovronsky (M.D., Ph.D., CEO and President of Avid ) 指出 "Today was a pivotal day for the entire Alzheimer's community, and a perfect example of the FDA and industry working together to successfully tackle a major public health challenge. This was a significant and positive milestone for Avid and we are very pleased with the feedback received. We look forward to continuing to work closely with the FDA to move our Phase III clinical program forward."
 
 
Update news for Alzheimer's / Dementia
Comments